BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37323038)

  • 1. ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure.
    Naimo GD; Forestiero M; Paolì A; Malivindi R; Gelsomino L; Győrffy B; Leonetti AE; Giordano F; Panza S; Conforti FL; Ruffo P; Panno ML; Mauro L; Andò S
    Int J Cancer; 2023 Sep; 153(6):1257-1272. PubMed ID: 37323038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.
    Mauro L; Naimo GD; Gelsomino L; Malivindi R; Bruno L; Pellegrino M; Tarallo R; Memoli D; Weisz A; Panno ML; Andò S
    FASEB J; 2018 Aug; 32(8):4343-4355. PubMed ID: 29513571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.
    Mauro L; Pellegrino M; De Amicis F; Ricchio E; Giordano F; Rizza P; Catalano S; Bonofiglio D; Sisci D; Panno ML; Andò S
    Cell Cycle; 2014; 13(4):553-64. PubMed ID: 24335340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
    Linher-Melville K; Zantinge S; Singh G
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.
    Li J; Liu J; Li P; Mao X; Li W; Yang J; Liu P
    J Exp Clin Cancer Res; 2014 Sep; 33(1):70. PubMed ID: 25178656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression.
    Andò S; Naimo GD; Gelsomino L; Catalano S; Mauro L
    Obes Rev; 2020 May; 21(5):e13004. PubMed ID: 32067339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells.
    Cardamone MD; Bardella C; Gutierrez A; Di Croce L; Rosenfeld MG; Di Renzo MF; De Bortoli M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7420-5. PubMed ID: 19383788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin.
    Wan X; Hou J; Liu S; Zhang Y; Li W; Zhang Y; Ding Y
    Front Cell Dev Biol; 2021; 9():583572. PubMed ID: 33614637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells.
    Zhang X; Zhang Y; Li Y
    Oncol Rep; 2013 Aug; 30(2):745-50. PubMed ID: 23732279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
    Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
    BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation.
    Albergaria A; Ribeiro AS; Pinho S; Milanezi F; Carneiro V; Sousa B; Sousa S; Oliveira C; Machado JC; Seruca R; Paredes J; Schmitt F
    Hum Mol Genet; 2010 Jul; 19(13):2554-66. PubMed ID: 20385540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 catalytic activity contributes to estrogen receptor alpha signaling.
    Nath-Sain S; Marignani PA
    Mol Biol Cell; 2009 Jun; 20(11):2785-95. PubMed ID: 19369417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
    Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
    J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
    Tan H; Zhong Y; Pan Z
    BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
    Liu H; Qiu J; Li N; Chen T; Cao X
    J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
    Fukui F; Hayashi SI; Yamaguchi Y
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
    Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
    Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis suppression by adiponectin: LKB1 rises up to the challenge.
    Saxena NK; Sharma D
    Cell Adh Migr; 2010; 4(3):358-62. PubMed ID: 20418665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.